Investigational diabetes drug that impedes Parkinson's progression getting ready for human trials

A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world’s first treatment to impede the progression of Parkinson’s disease following publication of research findings today in the journal Science Translational Medicine.

from Dementia Big http://ift.tt/2gcLPDO via alcoholic dementia

http://ift.tt/2ggtJkl